Vx1
Device Cardiovascular
General payments
$338,926
Research payments
$689,497
Through program year 2023, $338,926 in general payments and $689,497 in research payments were reported against Vx1 (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $273,963 | 182 |
| 2023 | Research | $422,323 | 41 |
| 2022 | General | $64,963 | 121 |
| 2022 | Research | $267,174 | 31 |
Breakdown
The top 5 of 73 recipients; each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 23 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
303 general · 72 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.